Current Capabilities and Services

This facility helps UC San Diego and external investigators transition cell therapies through IND-enabling and Phase I/II clinical studies. The ACTL features the following capabilities:
  • Optimizing manufacturing processes, including scale-up, closed systems, and delivery formats
  • Development of Standard Operating Procedures and Batch Production Records
  • Cell product manufacturing, including cell enrichment with the CliniMACS System
  • Cell product characterization, including standard microbiological release assays, flow cytometry and RT-qPCR assessment
  • Secure storage of cell banks and cell products
  • Materials risk assessment and selection
  • Writing or review of CMC or supporting reports
lab1 lab2 lab3 lab4 lab5